INTERNATIONAL PATENT: NOVELTY NOBILITY INC., 주식회사 노벨티노빌리티 FILES APPLICATION FOR "NOVEL ANTI-CDCP1 HUMANIZED ANTIBODY AND USE THEREOF"

GENEVA, Nov. 4 -- NOVELTY NOBILITY INC. (6th floor, 227, Unjung-ro,Bundang-gu, Seongnam-si,Gyeonggi-do 13477), 주식회사 노벨티노빌리티 (경기도성남시 분당구운중로 227, 6층) filed a patent application (PCT/KR2025/005443) for "NOVEL ANTI-CDCP1 HUMANIZED ANTIBODY AND USE THEREOF" on Apr 22, 2025. With publication no. WO/2025/226017, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PARK...